Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
8
350Ṁ185
2027
43%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against non-small-cell lung carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy